Phoenix Life
Sciences International Announces Presentation at MjMicro Cap
Conference in Preparation to Uplist to the OTCQB
Market
DENVER, CO –
May 29, 2019
-- InvestorsHub NewsWire -- Phoenix
Life Sciences International Limited (OTC:
PLSI) ("Phoenix Life" or the "Company"), an adaptive healthcare
solutions company, today announced that it will be presenting at
the
MjMicro Cap Conference on June 25, 2019 at the Westin
Grand Central in New York, New York in conjunction with the
recently announced share offering and international
expansion.
Phoenix Life
recently
announced that the Company had completed
filing its 2017 and 2018 financial audits and is now current with
respect to public reporting compliance with the SEC and the OTC
Markets. Now, having reached fully reporting status, the Company
intends to apply for uplisting to the OTCQB market in the near
future.
Phoenix Life
Founder and CEO, Martin Tindall will be presenting to prospective
investors about the Company's publicly traded stock and investment
into its Private Placement Memorandum.
"Phoenix Life is
honored to be one of only a handful of companies presenting to
cannabis-centric investors at the invitational MjMicro Cap
Conference," said Phoenix Life Founder and CEO Martin Tindall. "We
look forward to sharing Phoenix Life's message at the conference
and meeting potential partners in advancing our goal of
transforming the future of global healthcare."
Phoenix Life was
chosen as one of a small number of companies invited to present at
the MjMicro Cap Conference. Conference organizers specially select
established companies to present at MjMicro that have proof of
concept, revenue streams, audited financials and valuations
justified by public markets.
The MjMicro Cap
Conference is a one-day invitational forum that unites publicly
traded cannabis companies led by seasoned executives with next
level, high net worth investors looking for short-term return on
investments and guaranteed liquidity.
"After learning
about Phoenix Life's business model and audited financials, we are
honored to have them present at the MjMicro Cap Conference," said
Tripp Keber, MjMicro Conference Board Member and former CEO of
Dixie Brands, Inc. "We are proud to bring together leading cannabis
industry companies, like Phoenix Life, and high net worth
investors, to partner in moving forward their missions."
For more
information on Phoenix Life's capital raise and accompanying
Private Placement Memorandum, please visit the company's Investor
Portal at
http://invest.phoenixlife.co.
To learn more about
Phoenix Life Sciences International, please visit
https://phoenixlife.co/.
###
About Phoenix
Life Sciences International Limited
Phoenix
Life Sciences International Limited is an adaptive healthcare
solutions company. Our business is to advance research and
integrate programs and manufacturing of products that target and
treat diabetes, pain, cancer, and address psychological,
neurological, autoimmune and sleep disorders. We strive to create
partnerships and integrate these programs for human health into
communities worldwide as part of our Global Health
Initiative.
FORWARD-LOOKING
STATEMENTS
Information
contained in this press release regarding Phoenix Life Sciences
International, Limited and its subsidiaries, (the "Companies") may
constitute forward-looking statements or statements which may be
deemed or construed to be forward-looking statements. The words
"plan", "forecast", "anticipates", "estimate", "project", "intend",
"expect", "should", "believe," and similar expressions are intended
to identify forward-looking statements. These forward-looking
statements involve, and are subject to, known and unknown risks,
uncertainties and other factors which could cause the Company's
actual results, performance (financial or operating) or
achievements to differ from the future results, performance
(financial or operating) or achievements expressed or implied by
such forward-looking statements. The risks, uncertainties and other
factors are more fully discussed in the Company's filings with the
U.S. Securities and Exchange Commission. All forward-looking
statements attributable to the Companies herein are expressly
qualified in their entirety by the above-mentioned cautionary
statement. The Companies disclaim any obligation to update
forward-looking statements contained in this press release, except
as may be required by law.
FOOD AND DRUG
ADMINISTRATION (FDA) DISCLOSURE
These statements
have not been evaluated by the FDA and therefore the products sold
by Phoenix Life Sciences International are not available in the
U.S.
LEGAL
DISCLOSURE
Phoenix Life
Sciences International does not sell or distribute any products in
the United States that are in violation of the United States
Controlled Substances Act (US.CSA). This company does not grow,
sell, and distribute cannabis-based products in the United States
and is solely involved with the legal distribution of medical
cannabis-based products within certain international markets
outside of the United States.
Investor
Contact:
Phone:
1.888.717.5655 or international +1.720.699.7222
E-mail:
investor.relations@phoenixlife.co
Media
Contact:
Kathryn
Reinhardt
CMW
Media
Kathryn@cmwmedia.com
619-972-3089